Abstract:Objective To explore the efficacy of intratympanic corticosteroid injections combined with vestibular rehabilitation training for treating Meniere's disease.Methods Eighty-two patients with Meniere's disease who visited the Department of Otorhinolaryngology at the Second Affiliated Hospital of Shaanxi University of Chinese Medicine from June 2022 to December 2023 were randomly divided into an observation group and a control group, with 41 patients in each. The control group received intratympanic corticosteroid injections, while the observation group received combined vestibular rehabilitation training in addition to the injections. Tests including electrocochleography, pure tone audiometry, the Dizziness Handicap Inventory (DHI), the Berg Balance Scale (BBS), and the Self-Rating Anxiety Scale (SAS) were conducted before and after treatment, and a 6-month follow-up was performed to assess the prognosis.Results There was no statistically significant difference in the electrocochleography positivity rate between the control group and the observation group prior to treatment (P > 0.05). Following treatment, a statistically significant difference was observed between the two groups (P < 0.05), with the observation group exhibiting a lower electrocochleography positivity rate compared to the control group. The changes in hearing threshold, DHI scores, BBS scores, and SAS scores before and after treatment were significantly greater in the observation group than in the control group (P < 0.05). No significant difference was noted in the overall control rate between the two groups (P > 0.05); however, a statistically significant difference was found in the basic control rate (P < 0.05), with the observation group achieving a higher basic control rate than the control group.Conclusion Intratympanic corticosteroid injection combined with vestibular rehabilitation training is more effective than intratympanic corticosteroid injection alone in the treatment of Meniere's disease. It significantly improves patients' vertigo symptoms, hearing, and balance function, and is worth promoting for clinical use.